Furthermore, tumor suppressor liver kinase B1 (LKB1) as a negative regulator of mTOR signaling was specifically identified as being commonly mutated in lung cancer, highlighting a potential role of the mTOR pathway in the development of lung carcinogenesis [132]. This evidence concerns the gene MTOR and lung carcinoma.